Hot Stocks: Brokerages on PVR, TVS Motor and Gland Pharma
CLSA maintained its buy rating on PVR with a target price of Rs 2,410. The company saw a weak Bollywood & Hollywood show in Q2FY23, said CLSA, although it added that Q2FY23 revenue and EBITDA are a tad ahead of estimates. The current quarter has begun well and growing screens as well as a possible merger ahead are some of the key positives for the stock, said the note.
